Simple test could reveal uveal melanoma risk
Source: Insight News, June 2018
Patients with uveal melanoma may soon be able to avoid painful and potentially harmful biopsies thanks to a new blood test developed by Australian researchers.
Currently, patients with the rare cancer are required to either have a sample of tissue removed to determine if the tumour will become aggressive or undergo constant monitoring – in some cases for more than 10 years. However, by studying the genetic DNA of tumour cells in the bloodstream, a team from Edith Cowan University in Perth has developed a test that may be able to bypass both the invasive procedure and the years of uncertainty.